Category: Market/Novel Tech

Month: 02 Nov 2014

Issue: not yet available

Nicox SA completes purchase of Aciex Therapeutics, Inc. following shareholder approval of over 97%

Nicox S.A. (NYSE Euronext Paris: COX), a company focused on the ophthalmology medicines market has announced the approval by its shareholders for the acquisition of Aciex Therapeutics, Inc., a US-based, ophthalmic development company with lead programs in conjunctivitis and post-operative ocular inflammation. The transaction is understood to be scheduled for completion within a number of days.

Back to previous

Related News

Gearoid Tuohy

editor

by Dr. Gearóid Tuohy   Dear EURETINA Members,   A very warm welcome to the December 4th, 2017 edition of EURETINA’s web-based digital magazine, “EURETINA Brief”. EURETINA are delighted to continue our delivery of up-to-date summary briefs on a range of topics of interest to retinal clinicians, specialists and researchers across Europe. This resource is […]